We are live on ! Find out more
TSVT

2seventy bio

Delisted

TSVT was delisted on the 13th of May, 2025.

149 hedge funds and large institutions have $505M invested in 2seventy bio in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

184% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $407K

103% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 30

14% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 22

2% more funds holding

Funds holding: 146149 (+3)

1% less capital invested

Capital invested by funds: $508M → $505M (-$3.26M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
149
Holders Change
+3
Holders Change %
+2.05%
% of All Funds
2.34%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
25
Increased
61
Reduced
30
Closed
22
Calls
$1.16M
Puts
$407K
Net Calls
+$748K
Net Calls Change
+$456K
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$257K +$248K +23,396 +1,153%
PFCS
77
Pale Fire Capital SE
Czech Republic
$246K +$257K +24,288 New
AIG
78
American International Group
New York
$245K +$64.9K +6,130 +34%
Mitsubishi UFJ Asset Management
79
Mitsubishi UFJ Asset Management
Japan
$243K +$71.2K +6,722 +39%
Janus Henderson Group
80
Janus Henderson Group
United Kingdom
$235K +$104K +9,830 +74%
American Century Companies
81
American Century Companies
Missouri
$233K +$124K +11,744 +104%
Deutsche Bank
82
Deutsche Bank
Germany
$229K -$36.9K -3,482 -13%
Manulife (Manufacturers Life Insurance)
83
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$203K -$353K -33,357 -62%
T. Rowe Price Associates
84
T. Rowe Price Associates
Maryland
$202K -$6.21M -586,826 -97%
HWAM
85
Hennion & Walsh Asset Management
New Jersey
$197K -$148K -14,015 -42%
HKAM
86
Horizon Kinetics Asset Management
New York
$182K
New York State Common Retirement Fund
87
New York State Common Retirement Fund
New York
$174K -$487 -46 -0.3%
Principal Financial Group
88
Principal Financial Group
Iowa
$170K +$47.3K +4,471 +36%
AC
89
AXQ Capital
New Jersey
$168K +$176K +16,600 New
FT
90
Fiduciary Trust
Massachusetts
$153K
AQR Capital Management
91
AQR Capital Management
Connecticut
$149K +$9.49K +896 +6%
VRS
92
Virginia Retirement Systems
Virginia
$145K +$151K +14,300 New
State Board of Administration of Florida Retirement System
93
State Board of Administration of Florida Retirement System
Florida
$144K +$106 +10 +0.1%
GAA
94
Green Alpha Advisors
Colorado
$140K +$17.1K +1,612 +13%
IAN
95
Integrated Advisors Network
Texas
$137K +$144K +13,575 New
Mariner
96
Mariner
Kansas
$133K -$56.2K -5,308 -29%
ASRS
97
Arizona State Retirement System
Arizona
$128K +$23.8K +2,251 +22%
Franklin Resources
98
Franklin Resources
California
$128K +$212 +20 +0.2%
Walleye Trading
99
Walleye Trading
New York
$127K +$133K +12,555 New
EFM
100
E Fund Management
China
$126K -$1.92K -181 -1%

TSVT Hedge Fund Activity: Q2 2023 in Review

149 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in 2seventy bio (TSVT) for Q2 2023, worth a combined $505M — down 0.64% from $508M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TSVT positions and 22 closed out — a net gain of 3 holders — while 61 added to existing stakes and 30 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $14.2M. The largest seller was Citadel Advisors, cutting an estimated $22.9M.

  • 149 institutional investors held 2seventy bio (TSVT) as of Q2 2023, up from 146 in Q1 2023.
  • Funds reported $505M of 2seventy bio stock for Q2 2023, down 0.64% quarter-over-quarter.
  • 25 funds opened new 2seventy bio positions in Q2 2023 and 22 closed out, a net change of +3 holders.
  • The largest 2seventy bio buyer in Q2 2023 was Avidity Partners Management, an estimated $14.2M added.
  • The largest 2seventy bio seller in Q2 2023 was Citadel Advisors, an estimated $22.9M sold.

Based on aggregated 13F filings for Q2 2023.